macrolides azithromycin Search Results


90
European Directorate for the Quality of Medicines and HealthCare azithromycin
FIGURE 2 Mean dissolution profiles of 12 genuine products (code starting with G) and 19 illegal samples (code starting with I). A, amoxicillin of co‐amoxiclav (500 mg/125 mg); B, clavulanic acid of co‐amoxiclav (500 mg/125 mg); C, amoxicillin of co‐amoxiclav (875 mg/125 mg); D, clavulanic acid of co‐amoxiclav (875 mg/125 mg); E, amoxicillin 500 mg; F. <t>azithromycin</t> 250 mg; G, azithromycin 500 mg; H. sulfamethoxazole of co‐ trimoxazole (800 mg/160 mg); I, trimethoprim of co‐trimoxazole (800 mg/160 mg) [Colour figure can be viewed at wileyonlinelibrary.com]
Azithromycin, supplied by European Directorate for the Quality of Medicines and HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/Azithromycin+CRS/pm31454468-55-0-7
Average 90 stars, based on 1 article reviews
azithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson susceptibility disks containing the macrolides azithromycin, clarithromycin, erythromycin, telithromycin, and tilmicosin
FIGURE 2 Mean dissolution profiles of 12 genuine products (code starting with G) and 19 illegal samples (code starting with I). A, amoxicillin of co‐amoxiclav (500 mg/125 mg); B, clavulanic acid of co‐amoxiclav (500 mg/125 mg); C, amoxicillin of co‐amoxiclav (875 mg/125 mg); D, clavulanic acid of co‐amoxiclav (875 mg/125 mg); E, amoxicillin 500 mg; F. <t>azithromycin</t> 250 mg; G, azithromycin 500 mg; H. sulfamethoxazole of co‐ trimoxazole (800 mg/160 mg); I, trimethoprim of co‐trimoxazole (800 mg/160 mg) [Colour figure can be viewed at wileyonlinelibrary.com]
Susceptibility Disks Containing The Macrolides Azithromycin, Clarithromycin, Erythromycin, Telithromycin, And Tilmicosin, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/susceptibility+disks+containing+the+macrolides+azithromycin++clarithromycin++erythromycin++telithromycin++and+tilmicosin/10__1128_slash_aac__00060___11-71-10-14
Average 90 stars, based on 1 article reviews
susceptibility disks containing the macrolides azithromycin, clarithromycin, erythromycin, telithromycin, and tilmicosin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BIOFARMA Pharmaceutical macrolide azithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolide Azithromycin, supplied by BIOFARMA Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolide+azithromycin/pmc04039046-39-0-2
Average 90 stars, based on 1 article reviews
macrolide azithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Titan Biotech Ltd macrolides (azithromycin 15 mcg)
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolides (Azithromycin 15 Mcg), supplied by Titan Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolides++azithromycin+15+mcg+/bio_rxiv__2024__10__25__620196-55-16-6
Average 90 stars, based on 1 article reviews
macrolides (azithromycin 15 mcg) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BIOFARMA Pharmaceutical macrolides azithromycin biofarma
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolides Azithromycin Biofarma, supplied by BIOFARMA Pharmaceutical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolides+azithromycin+biofarma/pm21908042-64-0-2
Average 90 stars, based on 1 article reviews
macrolides azithromycin biofarma - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Clinical and Laboratory Standards Institute macrolides azithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolides Azithromycin, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolides+azithromycin/pmc06230626-403-15-3
Average 90 stars, based on 1 article reviews
macrolides azithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Blackwell Verlag macrolide azithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolide Azithromycin, supplied by Blackwell Verlag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolide+azithromycin/pm20629652-31-24-3
Average 90 stars, based on 1 article reviews
macrolide azithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Informa UK Limited macrolide antibiotic azithromycin or clarithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolide Antibiotic Azithromycin Or Clarithromycin, supplied by Informa UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolide+antibiotic+azithromycin+or+clarithromycin/pm33567928-28-41-26
Average 90 stars, based on 1 article reviews
macrolide antibiotic azithromycin or clarithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Nabriva Therapeutics macrolide antibioticsdmacrolonesdderived from azithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolide Antibioticsdmacrolonesdderived From Azithromycin, supplied by Nabriva Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/macrolide+antibioticsdmacrolonesdderived+from+azithromycin/pm21600677-13-38-3
Average 90 stars, based on 1 article reviews
macrolide antibioticsdmacrolonesdderived from azithromycin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Pfizer Inc macrolide antibiotic zithromax azithromycin
Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of <t>azithromycin</t> or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.
Macrolide Antibiotic Zithromax Azithromycin, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/macrolides+azithromycin/antibiotic+azithromycin+macrolide+zithromax/10__1038_slash_scibx__2010__17-5-1-0
Average 86 stars, based on 1 article reviews
macrolide antibiotic zithromax azithromycin - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


FIGURE 2 Mean dissolution profiles of 12 genuine products (code starting with G) and 19 illegal samples (code starting with I). A, amoxicillin of co‐amoxiclav (500 mg/125 mg); B, clavulanic acid of co‐amoxiclav (500 mg/125 mg); C, amoxicillin of co‐amoxiclav (875 mg/125 mg); D, clavulanic acid of co‐amoxiclav (875 mg/125 mg); E, amoxicillin 500 mg; F. azithromycin 250 mg; G, azithromycin 500 mg; H. sulfamethoxazole of co‐ trimoxazole (800 mg/160 mg); I, trimethoprim of co‐trimoxazole (800 mg/160 mg) [Colour figure can be viewed at wileyonlinelibrary.com]

Journal: Drug testing and analysis

Article Title: Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in Belgium.

doi: 10.1002/dta.2690

Figure Lengend Snippet: FIGURE 2 Mean dissolution profiles of 12 genuine products (code starting with G) and 19 illegal samples (code starting with I). A, amoxicillin of co‐amoxiclav (500 mg/125 mg); B, clavulanic acid of co‐amoxiclav (500 mg/125 mg); C, amoxicillin of co‐amoxiclav (875 mg/125 mg); D, clavulanic acid of co‐amoxiclav (875 mg/125 mg); E, amoxicillin 500 mg; F. azithromycin 250 mg; G, azithromycin 500 mg; H. sulfamethoxazole of co‐ trimoxazole (800 mg/160 mg); I, trimethoprim of co‐trimoxazole (800 mg/160 mg) [Colour figure can be viewed at wileyonlinelibrary.com]

Article Snippet: Azithromycin and lithium clavulanate were obtained from EDQM (Strasbourg, France).

Techniques: Dissolution

Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of azithromycin or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.

Journal: Journal of Translational Medicine

Article Title: Azithromycin is able to control Toxoplasma gondii infection in human villous explants

doi: 10.1186/1479-5876-12-132

Figure Lengend Snippet: Analysis of cytotoxicity in human villous explants. Villous explant supernatants were collected and lactate dehydrogenase (LDH) activity was measured using the LDH Liquiform kit. The positive control was established by adding 0.2% Triton X-100 (A) . Human villous explants were infected or not by T. gondii and treated with increasing concentrations of azithromycin or PSA for 24 h and the percentage of tissue toxicity was analyzed (B) . Data are expressed as mean ± SEM. Significant differences were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001 in relation to the positive control; ΦΦ P < 0.01 between uninfected and infected villous explants.

Article Snippet: Macrolide azithromycin (Biofarma, Uberlândia, MG, Brazil) or a drug combination consisting of pyrimethamine (Daraprim® - Farmoquímica, Rio de Janeiro, RJ, Brazil), sulfadiazine (Suladrin®- Laboratório Catarinense, Joinville, SC, Brazil) and folinic acid (Genix, Anápolis, GO, Brazil) (PSA) were dissolved in culture medium to a concentration of 5000 μg/mL (stock solution).

Techniques: Activity Assay, Positive Control, Infection, Comparison

T. gondii intracellular proliferation in villous explants treated with azithromycin or PSA. Villous explants were infected and treated for 72 h with azithromycin or PSA at different concentrations. T. gondii proliferation was measured by a colorimetric β-galactosidase assay (A) . The bars represent mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. Significant differences in comparison with untreated villous explants are labeled ( *** P < 0.001; ** P < 0.01). Representative photomicrographs of human villous explants infected or not with T. gondii : uninfected human villous explants as a negative control (B) , arrows indicate tachyzoites in untreated human villous explants (C) , azithromycin-treated (D) and PSA-treated (E) human villous explants. Arrowheads indicate syncytiotrophoblast layers, and M indicates mesenchymal tissue. Counterstaining with Mayer’s hematoxylin was performed. Scale bar: 10 μm.

Journal: Journal of Translational Medicine

Article Title: Azithromycin is able to control Toxoplasma gondii infection in human villous explants

doi: 10.1186/1479-5876-12-132

Figure Lengend Snippet: T. gondii intracellular proliferation in villous explants treated with azithromycin or PSA. Villous explants were infected and treated for 72 h with azithromycin or PSA at different concentrations. T. gondii proliferation was measured by a colorimetric β-galactosidase assay (A) . The bars represent mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. Significant differences in comparison with untreated villous explants are labeled ( *** P < 0.001; ** P < 0.01). Representative photomicrographs of human villous explants infected or not with T. gondii : uninfected human villous explants as a negative control (B) , arrows indicate tachyzoites in untreated human villous explants (C) , azithromycin-treated (D) and PSA-treated (E) human villous explants. Arrowheads indicate syncytiotrophoblast layers, and M indicates mesenchymal tissue. Counterstaining with Mayer’s hematoxylin was performed. Scale bar: 10 μm.

Article Snippet: Macrolide azithromycin (Biofarma, Uberlândia, MG, Brazil) or a drug combination consisting of pyrimethamine (Daraprim® - Farmoquímica, Rio de Janeiro, RJ, Brazil), sulfadiazine (Suladrin®- Laboratório Catarinense, Joinville, SC, Brazil) and folinic acid (Genix, Anápolis, GO, Brazil) (PSA) were dissolved in culture medium to a concentration of 5000 μg/mL (stock solution).

Techniques: Infection, Comparison, Labeling, Negative Control

Cytokine production by T. gondii -infected villous explants after treatment with azithromycin or PSA. Supernatants of villous explants were collected after 24 h of treatment and production of TNF-α (A) , IL-17A (B) , TGF-β1 (C) , IL-10 (D) , IL-12 (E) and IL-6 (F) were measured by a CBA or ELISA. The continuous line represents the parasite load. Data are expressed as mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. ### P < 0.001; ## P < 0.01 and # P < 0.05 in relation to NT control.

Journal: Journal of Translational Medicine

Article Title: Azithromycin is able to control Toxoplasma gondii infection in human villous explants

doi: 10.1186/1479-5876-12-132

Figure Lengend Snippet: Cytokine production by T. gondii -infected villous explants after treatment with azithromycin or PSA. Supernatants of villous explants were collected after 24 h of treatment and production of TNF-α (A) , IL-17A (B) , TGF-β1 (C) , IL-10 (D) , IL-12 (E) and IL-6 (F) were measured by a CBA or ELISA. The continuous line represents the parasite load. Data are expressed as mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. ### P < 0.001; ## P < 0.01 and # P < 0.05 in relation to NT control.

Article Snippet: Macrolide azithromycin (Biofarma, Uberlândia, MG, Brazil) or a drug combination consisting of pyrimethamine (Daraprim® - Farmoquímica, Rio de Janeiro, RJ, Brazil), sulfadiazine (Suladrin®- Laboratório Catarinense, Joinville, SC, Brazil) and folinic acid (Genix, Anápolis, GO, Brazil) (PSA) were dissolved in culture medium to a concentration of 5000 μg/mL (stock solution).

Techniques: Infection, Enzyme-linked Immunosorbent Assay, Comparison, Control

Detection of sex hormones and parasite load in uninfected and T. gondii -infected villous explants, treated or not with azithromycin or PSA. Estradiol (A) , progesterone (B) and HCG + β (C) were measured by an electrochemiluminescence immunoassay of uninfected or T. gondii- infected villous explants. Levels of (D) estradiol, (E) progesterone, and (F) HCG + β in azithromycin- or PSA-treated or untreated villous explants were analyzed in relation to parasite load. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. Comparisons are represented by symbols: parasitism, *** P < 0.001, ** P < 0.01, * P < 0.05 and sexual hormones, ### P < 0.001, ## P < 0.01, # P < 0.05 in relation to NT control.

Journal: Journal of Translational Medicine

Article Title: Azithromycin is able to control Toxoplasma gondii infection in human villous explants

doi: 10.1186/1479-5876-12-132

Figure Lengend Snippet: Detection of sex hormones and parasite load in uninfected and T. gondii -infected villous explants, treated or not with azithromycin or PSA. Estradiol (A) , progesterone (B) and HCG + β (C) were measured by an electrochemiluminescence immunoassay of uninfected or T. gondii- infected villous explants. Levels of (D) estradiol, (E) progesterone, and (F) HCG + β in azithromycin- or PSA-treated or untreated villous explants were analyzed in relation to parasite load. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. Comparisons are represented by symbols: parasitism, *** P < 0.001, ** P < 0.01, * P < 0.05 and sexual hormones, ### P < 0.001, ## P < 0.01, # P < 0.05 in relation to NT control.

Article Snippet: Macrolide azithromycin (Biofarma, Uberlândia, MG, Brazil) or a drug combination consisting of pyrimethamine (Daraprim® - Farmoquímica, Rio de Janeiro, RJ, Brazil), sulfadiazine (Suladrin®- Laboratório Catarinense, Joinville, SC, Brazil) and folinic acid (Genix, Anápolis, GO, Brazil) (PSA) were dissolved in culture medium to a concentration of 5000 μg/mL (stock solution).

Techniques: Infection, Electrochemiluminescence, Comparison, Control

T. gondii intracellular proliferation in villous explants infected with pretreated (azithromycin or PSA) parasites. Proliferation was measured by a colorimetric β-galactosidase assay. The bars represent mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001, ** P < 0.01 and * P < 0.05 in relation to NTp control. Φ Comparison between villous explants treated with different concentrations of azithromycin (P < 0.05).

Journal: Journal of Translational Medicine

Article Title: Azithromycin is able to control Toxoplasma gondii infection in human villous explants

doi: 10.1186/1479-5876-12-132

Figure Lengend Snippet: T. gondii intracellular proliferation in villous explants infected with pretreated (azithromycin or PSA) parasites. Proliferation was measured by a colorimetric β-galactosidase assay. The bars represent mean ± SEM. Data were analyzed by ANOVA and Bonferroni multiple comparison post hoc test. *** P < 0.001, ** P < 0.01 and * P < 0.05 in relation to NTp control. Φ Comparison between villous explants treated with different concentrations of azithromycin (P < 0.05).

Article Snippet: Macrolide azithromycin (Biofarma, Uberlândia, MG, Brazil) or a drug combination consisting of pyrimethamine (Daraprim® - Farmoquímica, Rio de Janeiro, RJ, Brazil), sulfadiazine (Suladrin®- Laboratório Catarinense, Joinville, SC, Brazil) and folinic acid (Genix, Anápolis, GO, Brazil) (PSA) were dissolved in culture medium to a concentration of 5000 μg/mL (stock solution).

Techniques: Infection, Comparison, Control